0001181431-11-036552.txt : 20110614 0001181431-11-036552.hdr.sgml : 20110614 20110614164650 ACCESSION NUMBER: 0001181431-11-036552 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110610 FILED AS OF DATE: 20110614 DATE AS OF CHANGE: 20110614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Viveash Dawn CENTRAL INDEX KEY: 0001475720 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33415 FILM NUMBER: 11911031 MAIL ADDRESS: STREET 1: 3344 N. TORREY PINES CT., SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Orexigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001382911 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 651178822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3344 N. TORREY PINES CT. STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 875-8600 MAIL ADDRESS: STREET 1: 3344 N. TORREY PINES CT. STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 rrd315185.xml VIVEASH JUNE GRANT X0303 4 2011-06-10 0 0001382911 Orexigen Therapeutics, Inc. OREX 0001475720 Viveash Dawn C/O OREXIGEN THERAPEUTICS, INC. 3344 N. TORREY PINES COURT, SUITE 200 LA JOLLA CA 92037 0 1 0 0 SVP/Head of Regulatory Affairs Stock Option (right to buy) 1.69 2011-06-10 4 A 0 72000 A 2021-06-09 Common Stock 72000 72000 D 1/48th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each one-month period of the reporting persons service as an employee, director or consultant following June 10, 2011, so that all of the shares of the stock subject to the option shall be vested on June 10, 2015, subject to the reporting persons continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary on each such date. Not applicable. /s/ Heather D. Turner, Attorney-in-Fact 2011-06-14